Literature DB >> 12823224

Aberrant subclavian artery causing difficulty in transhiatal esophageal dissection.

C S Pramesh1, A P Saklani, V Parmar, S Acharya, R A Badwe.   

Abstract

The right subclavian artery normally arises from the brachiocephalic artery. Anomalies in development may lead to peculiar problems during surgery. We report a patient with esophageal carcinoma who had an aberrant right subclavian artery, posing specific difficulties during a transhiatal esophagectomy, requiring conversion of the procedure into a transthoracic approach. The embryologic basis of this anomaly and the clinical significance are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12823224     DOI: 10.1046/j.1442-2050.2003.00322.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  5 in total

1.  Aberrant right subclavian artery in video-assisted thoracoscopic esophagectomy.

Authors:  Yidan Lin; Mingxia Li; Xian Liu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Pharyngolaryngoesophagectomy in a patient with an aberrant right subclavian artery: report of a case.

Authors:  Predrag Sabljak; Dejan Stojakov; Lazar Davidovic; Aleksandar Ivanovic; Keramatollah Ebrahimi; Dejan Velickovic; Predrag Pesko
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

3.  Diagnosis and surgical treatment of esophageal carcinoma with coexistent intrathoracic vascular malformations.

Authors:  Zhong-Xi Niu; Qiang Gao; Jun Peng; Hui Shi; Long-Qi Chen
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

4.  Aberrant Right Subclavian Artery: A Life-threatening Anomaly that should be considered during Esophagectomy.

Authors:  Rahim Mahmodlou; Nariman Sepehrvand; Sanaz Hatami
Journal:  J Surg Tech Case Rep       Date:  2014 Jul-Dec

5.  Aberrant right subclavian artery with atrial septal defect: Simultaneous repair via median sternotomy.

Authors:  Hina Inam; Abdul Ahad Sohail; Narmeen Asif; Waris Ahmad
Journal:  Int J Surg Case Rep       Date:  2020-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.